CAY-I, a novel antifungal compound from cayenne pepper

References

• Bow El. Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer. Br J Haematol 1998; 101: 1–4.
   Google Scholar
• Warnock DW. Fungal infections in neutropenia: current problems and chemotherapeutic control. J Antimicrob Che-mother 1998; 41: 95–105.
   PubMedGoogle Scholar
• Alexander BD, Perfect JR. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. Drugs 1997; 54: 657–678.
   Google Scholar
• Boschman CR, Bodmar UR, Tornatore MA, et al. Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center. Antimicrob Agents Chemother 1998; 42: 734–738.
   PubMed Web of Science ®Google Scholar
• Waller OR, Yamasaki K (eds). Saponins Used in Traditional and Modern Medicine. New York: Plenum Press, 1996.
   Google Scholar
• De Lucca AJ, Bland JM, Vigo M, et al. CAY-1, a fungicidal saponin from Capsicum sp. fruit. Med Mycol 2002; 40: 131–137.
   PubMedGoogle Scholar
• Vogel HJ. A convenient growth medium for Neurospora. Genet Bull 1956; 13: 42–43.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M-27A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
   Google Scholar
• White RL, Burgess DS, Manduru M, et al. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard and E test. Antimicrob Agents Chemother 1996; 40: 1914–1918.
   PubMed Web of Science ®Google Scholar
• Weinstein RJ, Young LS, Hewitt WL. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia. J Lab Clin Med 1975; 86: 853–862.
   Google Scholar
• Roberts WK, Selitrennikoff CP. Zeamatin, an antifungal protein from maize with membrane-permeabilizing activity. J Gen Microbiol 1990; 136: 1771–1778.
   Google Scholar
• Taft CS, Enderlin CS, Selitrennikoff CP. A high throughput in vitro assay for fungal (1,3)13-glucan synthase inhibitors. J Antibiotics 1994; 47: 1001–1009.
   Google Scholar
• Wood RL, Miller TK, Wright A, et al. Characterization and optimization of in vitro assay conditions for (1,3)13-glucan synthase activity from Aspergillus fumigatus and Candida albicans for enzyme inhibition screening. J Antibiotics 1998; 51: 665–675.
   PubMedGoogle Scholar
• Nakata M, O'Rourke R, Wilson S, et al. A novel assay for fungal ketol-isomerase activity. J Antibiotics 2001; 54: 737–743.
   PubMedGoogle Scholar
• Choi WJ, Sburlati A, Cabib E. Chitin synthase 3 from yeast has zymogenic properties that depend on both the CAL1 and the CAL3 genes. Proc Natl Acad Sci 1994; 91: 4727–4730.
   Google Scholar
• Barchiesi F, Francesco LF, Compagnucci P, et al. In vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother 1998; 41: 59–65.
   PubMedGoogle Scholar
• Ekabo OA, Farnsworth NR, Henderson TO, et al. Antifungal and molluscicidal saponins from Serjania salzmanniana. J Nat Prod 1996; 59: 431–435.
   PubMedGoogle Scholar
• Mshvildadze V, Favel A, Delmas F, et al. Antifungal and antiprotozoal activities of saponins from Hedera colchica. Pharmazie 2000; 55: 325–326.
   PubMed Web of Science ®Google Scholar
• Zehavi U, Polacheck I. Saponins as antimycotic agents: glyco-sides of medicagenic acid. In: Waller OR, Yamasaki K, eds. Saponins Used in Traditional and Modern Medicine. New York: Plenum Press, 1996: 535–544.
   Google Scholar
• Polacheck I, Zehavi U, Naim M, et al. The susceptibility of Cryptococcus neoformans to an antimycotic agent (02) from alfalfa. Zbl Bakt Hyg 1986; A 261: 481–486.
   Google Scholar
• Okunji CO, Iwu MM, Jackson JE, et al. Biological activity of saponins from two Dracaena species. In: Waller OR, Yamasaki K, eds. Saponins Used in Traditional and Modern Medicine. New York: Plenum Press, 1996: 415–428.
   Google Scholar
• Polacheck I, Zehavi U, Naim M, et al. Activity of compound 02 isolated from alfalfa roots against medically important yeasts. Antimicrob Agents Chemother 1986; 30: 290–294.
   PubMed Web of Science ®Google Scholar
• Ridoux O, Di Giorgio C, Delmas F, et al. In vitro antileishma-nial activity of three saponins isolated from ivy, ek-hederin, 13-hederin and hederacolchiside A1, in association with pentami-dine and amphotericin B. Phytother Res 2001; 15: 298–301.
   PubMed Web of Science ®Google Scholar
• Lalitha T, Venkataraman LV. Antifungal activity and mode of action of saponins from Madhuca butyracea Macb. Ind j Exp Bio 1991; 29: 558–562.
   PubMed Web of Science ®Google Scholar
• Moulin-Traffort J, Favel A, Elias R, et al. Study of the action of a-hederin on the ultrastructure of Candida albicans. Mycoses 1998; 41: 411–416.
   Google Scholar
• Polacheck I, Levy M, Guizie M, et al. Mode of action of the antimycotic agent 02 isolated from alfalfa roots. Zbl Bakt 1991; 275: 504–512.
   PubMedGoogle Scholar
• Gruiz K. Fungitoxic activity of saponins: practical use and fundamental principles. In: Waller OR, Yamasaki K, eds. Saponins Used in Traditional and Modern Medicine. New York: Plenum Press, 1996: 527–533.
   Google Scholar
• Nakamura T, Inoue K, Nojima S, et al. Interactions of saponins with red blood cell membranes as well as with their phospha-tidylcholine liposomal membranes. J Pharmacobiol Dyn 1979; 2: 374.
   Google Scholar
• Mimaki Y, Kuroda M, Ide A, et al. Steroidal saponins from the aerial parts of Dracaena draco and their cytostatic activity of HL-60 cells. Phytochemistry 1999; 50: 805–813.
   PubMedGoogle Scholar
• Mimaki Y, Kameyama A, Kuroda M, et al. Steroidal glycosides from the underground parts of Hosta plantaginea var. japonica and their cytostatic activity of leukaemia HL-60 cells. Phyto-chemistry 1997; 44: 305–310.
   Google Scholar